Cowealth Medical Holding Co., Ltd. (TPEX:4745)
Taiwan · Delayed Price · Currency is TWD 18.75
-0.30 (-1.57%)
Apr 20, 2026, 12:35 PM CST
Cowealth Medical Holding Revenue
In the year 2025, Cowealth Medical Holding had annual revenue of 2.96B TWD, down -29.49%. Cowealth Medical Holding had revenue of 571.89M in the quarter ending December 31, 2025, a decrease of -44.17%.
Revenue
2.96B
Revenue Growth
-29.49%
P/S Ratio
0.50
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.96B | -1.24B | -29.49% |
| Dec 31, 2024 | 4.19B | -619.85M | -12.88% |
| Dec 31, 2023 | 4.81B | -813.80M | -14.46% |
| Dec 31, 2022 | 5.63B | 486.62M | 9.47% |
| Dec 31, 2021 | 5.14B | 417.81M | 8.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.80B |
| Wellell | 2.40B |
| OK Biotech | 1.56B |
| AViTA | 936.39M |
| Bioptik Technology Incorporation | 837.19M |
| Diamond Biotechnology | 698.11M |
| Applied BioCode | 475.20M |
| Wiltrom | 311.77M |